CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...